Please wait ...

Anne Wagner, PhD, C Psych

Anne Wagner, PhD, CPsych, Adjunct Professor, Department of Psychology & Associate Member, Yeates School of Graduate Studies at Ryerson University, Toronto. Trainer in CBCT and CPT. Team member, MDMA trial for Cognitive Behavioral Conjoint Therapy (CBCT) for PTSD. Founder of Remedy (, a centre for mental health innovation.

Speaker Disclosures:
Financial: Anne Wagner is the founder of Remedy and Remedy Institute. She has an employment relationship with Ryerson University. Anne Wagner receives a speaking honorarium and recording royalties from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Anne Wagner is a member of the Canadian Psychological Association, the International Society of Traumatic Stress Studies, and Association for Behavioral and Cognitive Therapies. She is an Ad hoc reviewer and editor for several peer review journals, for a complete list contact PESI, Inc.

The Use of Mind-Altering Substances: MDMA, Psilocybin, and Marijuana for Treating PTSD and other Mental Distress

Credit available - Click Here for more information

Michael Mithoefer, MD |  Rick Doblin, PhD |  Phil Wolfson, MD |  Sue Carter, PhD |  Robin Carhart-Harris, PhD |  Andrew Penn, RN, MS, NP, CNS, APRN-BC |  Richard C. Schwartz, PhD |  Anne Wagner, PhD, C Psych |  ....
3 Hours 59 Minutes
Audio and Video
May 18, 2021
Product Code:
Media Type:
Digital Seminar
$99.00 - 2022 Memorial Day Sale Standard - $179.99

Showing 1 to 2 of 2 entries